| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |